Indeed, FBXL10 is not only highly expressed in 53% of DLBCL patient samples examined (Table 1), but also overexpressed in FL and Burkitt lymphoma that both originate GC B cells whether in patient samples or cell lines (data not shown). Here, KDM2B is linked to Burkitt lymphoma.